Nanoparticles were prepared with poly(lactide-co-glycolide), Pluronic F127, and phospholipids and loaded with retinyl palmitate. Morphology and physicochemical properties of these nanoparticles were determined by atomic force microscopy, light scattering, and zeta potential. The elasticity and deformability of the nanoparticles were correlated to Tg values measured by differential scanning calorimetry. The in vitro cytotoxicity and genotoxicity of the nanosystems were determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, cell membrane asymmetry, and Ames tests with BALB/3T3 mouse embryo fibroblasts and HaCaT human keratinocytes cell lines. The reactive oxygen species levels and cytokine production in response to the exposure of cells to these nanoparticles were investigated, as well as the penetration in human skin culture.
BaumannL. Skin ageing and its treatment. J Pathol2007; 211: 241–251.
2.
ChiuAKimballAB. Topical vitamins, minerals and botanical ingredients as modulators of environmental and chronological skin damage. Br J Dermatol2003; 149: 681–691.
3.
GriffithsCE. The role of retinoids in the prevention and repair of aged and photoaged skin. Clin Exp Dermatol2001; 26: 613–618.
4.
BaroliB. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality?J Pharm Sci2010; 99(1): 21–50.
5.
KüchlerSRadowskiMRBlaschkeT. Nanoparticles for skin penetration enhancement—a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. Eur J Pharm Biopharm2009; 71:243–250.
6.
SachsDLVoorheesJJ. Age-reversing drugs and devices in dermatology. Clin Pharmacol Ther2011; 89(1): 34–43.
7.
SinghMGriffithsCE. The use of retinoids in the treatment of photoaging. Dermatol Ther2006; 19: 297–305.
8.
ArayachukeatSWanichwecharungruangSPTree-UdomT. Retinyl acetate-loaded nanoparticles: dermal penetration and release of the retinyl acetate. Int J Pharm2010; 404: 281–288.
9.
SauratJH. Retinoids and psoriasis: novel issues in retinoid pharmacology and implications for psoriasis treatment. J Am Acad Dermatol1999; 41(3 Pt 2): S2–S6.
10.
BosJDSpulsPI. Topical treatments in psoriasis: today and tomorrow. Clin Dermatol2008; 26: 432–437.
11.
Van De KerkhofPC. Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology. Dermatol Ther2006; 19: 252–263.
12.
KligmanAMGroveGLHiroseR. Topical tretinoin for photoaged skin. J Am Acad Dermatol1986; 15(4 Pt 2): 836–859.
13.
Schäfer-KortingMMehnertWKortingHC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev2007; 59: 427–443.
14.
SchneiderMStrackeFHansenS. Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol2009; 1: 197–206.
15.
GuterresSSAlvesMPPohlmannAR. Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications. Drug Target Insights2007; 2: 147–157.
16.
De O MonteiroEBaumannLS. The science of cosmeceuticals. Expet Rev Dermatol2006; 1: 379–389.
17.
DongYFengSS. In vitro and in vivo evaluation of methoxy poly(ethylene glycol)–poly(lactide acid) (MPEG–PLA) nanoparticles for small-molecule drug chemotherapy. Biomaterials2007; 28: 4154–4160.
18.
TeixeiraZZanchettaBMeloBA. Retinyl palmitate flexible polymeric nanocapsules: characterization and permeation studies. Colloids Surf B Biointerfaces2010; 8: 374–380.
19.
CarelliAABrevedanMIVCrapisteGH. Quantitative determination of phospholipids in sunflower oil. J Am Oil Chem Soc1997; 74(5): 511–514.
20.
KimJShimJKimYJ. The design of polymer-based nanocarriers for effective transdermal delivery. Macromol Biosci2010; 10: 1171–1176.
21.
ChenYWanYWangY. Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles. Int J Nanomedicine2011; 6: 2321–2326.
22.
TangHGuoJSunY. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery. Int J Pharm2011; 421: 388–396.
23.
YangYQuYLüX. Global gene expression analysis of the effects of gold nanoparticles on human dermal fibroblasts. J Biomed Nanotechnol2010; 6: 234–246.
24.
TianFCuiDSchwarzH. Cytotoxicity of single-wall carbon nanotubes on human fibroblasts. Toxicol In Vitro2006; 20: 1202–1212.
25.
ZhangLWZengLBarronAR. Biological interactions of functionalized single-wall carbon nanotubes in human epidermal keratinocytes. Int J Toxicol2007; 26: 103–113.
26.
Monteiro-RiviereNAInmanAOZhangLW. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol2009; 234: 222–235.
SchanenBCKarakotiASSealS. Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct. ACS Nano2009; 3: 2523–2532.
29.
RoncaroloMGBattagliaMGregoriS. The role of interleukin 10 in the control of autoimmunity. J Autoimmun2003; 20: 269–272.
30.
GrouxHCottrezF. The complex role of interleukin-10 in autoimmunity. J Autoimmun2004; 20: 281–285.
31.
MatsuzawaASaegusaKNoguchiT. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol2005; 6: 587–592.
32.
TomodaKWatanabeASuzukiK. Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis. Colloids Surf B Biointerfaces2012; 97: 84–89.
33.
KubowiczSSchmidRMilnerYSorokaYZlotkinMOronM. Development of polyurethane based submicron sized drug delivery systems for personalized treatment of skin diseases (2010). Proceedings of the 37th Annual Meeting of the Controlled Released Society (Portland, Oregon, USA). Controlled Release Society (St. Paul, MN, USA) ISBN 978-1-61782-022-9; 79–80.
34.
TomodaKTerashimaHSuzukiK. Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis. Colloids Surf B Biointerfaces2011; 88: 706–710.
35.
DesaiMPLabhasetwarVWalterE. The mechanism of uptake of biodegradable microparticles in caco-2 cells is size dependent. Pharm Res1997; 14(11): 1568–1573.
36.
ZhangWGaoJZhuQ. Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles. Int J Pharm2010; 402: 205–212.
